World’s Top Oncologists to Convene in Seoul, Korea

[RandyW]

Making Lung Cancer History: World’s Top Oncologists to Convene in Seoul, Korea

IASLC Presents 12th World Conference on Lung Cancer September 2-6, 2007

AURORA, Colo.--(BUSINESS WIRE)--While lung cancer remains the leading cause of cancer deaths in the world, there has been a significant increase in new scientific data reviewing prevention and treatment in lung cancer. The world’s top lung cancer specialists, medical professionals and researchers will gather in Seoul, Korea, to take part in the 12th World Conference on Lung Cancer organized by the International Association for the Study of Lung Cancer (IASLC).

The IASLC will showcase research in a robust press program, providing reporters with access to leading lung cancer experts and breakthrough clinical trials. The press program will feature a number of newsworthy abstracts that address the latest issues in lung cancer staging, detection, diagnosis and treatment. For more information or to register for the meeting, please visit http://www.2007worldlungcancer.org/ or www.iaslc.org.

Meeting Highlights:

The IASLC Lung Cancer Staging Project

Results of Novel Vaccines and Immunotherapy

Molecular Targeted Therapy for Lung Cancer

Smoking Status and Gender Related Lung Cancer Risk

Developing Biomarkers and Accurate Diagnostics for Lung Cancer

The Direction of Early Detection of Lung Cancer

Novel Surgical Techniques for Lung Cancer

IASLC Press Details:

COEX Convention Center

Samsung-Dong, Kangnam-gu

Seoul 135-731, KOREA

Press Room: Room 333

Press Conference Room: Room 334

Stay tuned for official IASLC press conference information, to be released in August. Press materials and teleconferences will be available to U.S. and international media.

Founded in 1972, the International Association for the Study of Lung Cancer (IASLC) is an international organization of 2,000 lung cancer specialists, spanning 53 countries. IASLC members work towards developing and promoting the study of etiology, epidemiology, prevention, diagnosis, treatment and all other aspects of lung cancer. IASLC’s mission is to enhance the understanding and education of lung cancer to scientists, members of the medical community and the public. In addition to the biannual meeting, the IASLC publishes the Journal of Thoracic Oncology, a prized resource for medical specialists and scientists who focus on the detection, prevention, diagnosis and treatment of lung cancer.